{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:49:16Z","timestamp":1773665356897,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"OPO"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.tiv.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T16:17:19Z","timestamp":1404317839000},"page":"1274-1279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interaction of injectable neurotropic drugs with the red cell membrane"],"prefix":"10.1016","volume":"28","author":[{"given":"Walter H.","family":"Reinhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabina","family":"Lubszky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Th\u00f6ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schulzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2014.06.008_b0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07091.x","article-title":"Disorders of red cell membrane","volume":"141","author":"An","year":"2008","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.tiv.2014.06.008_b0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2141.1997.4003212.x","article-title":"The antineoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology","volume":"99","author":"Baerlocher","year":"1997","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.tiv.2014.06.008_b0015","first-page":"721","article-title":"Red cell shapes: an illustrated classification and its rationale","volume":"12","author":"Bessis","year":"1972","journal-title":"Nouv. Rev. Franc. Hematol."},{"key":"10.1016\/j.tiv.2014.06.008_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2736(87)90126-X","article-title":"Modulation of erythrocyte vesiculation by amphiphilic drugs","volume":"901","author":"Butikofer","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.06.008_b0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(85)90049-4","article-title":"Effects of anesthetic and anticonvulsant drugs on calcium-dependent efflux of potassium from human erythrocytes","volume":"107","author":"Caldwell","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.febslet.2009.12.049","article-title":"Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes","volume":"584","author":"Contreras","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2014.06.008_b0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.2042-7158.1970.tb08496.x","article-title":"Plasma protein binding of chlorpromazine","volume":"22","author":"Curry","year":"1970","journal-title":"J. Phram. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0005-2736(68)90078-3","article-title":"Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and change of ionic environment","volume":"163","author":"Deuticke","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.06.008_b0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0006-2952(77)90326-4","article-title":"Fluorescence studies of membrane interactions of chlorpromazine and chlorimipramine","volume":"15","author":"Elferink","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0055","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1083\/jcb.98.6.1992","article-title":"Phosphoinositide metabolism and the morphology of human erythrocytes","volume":"98","author":"Ferrell","year":"1984","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tiv.2014.06.008_b0065","first-page":"79","article-title":"Influence of a parenteral fish-oil preparation (Omegaven\u00ae) on erythrocyte morphology and blood viscosity","volume":"28","author":"Fischler","year":"2003","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.tiv.2014.06.008_b0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0006-2952(79)90144-8","article-title":"Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cell","volume":"28","author":"Fujii","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ajcp\/64.1.75","article-title":"Diphenylhydantoin and fragility of erythrocytes in normal subjects and in patients with hereditary spherocytic anemia","volume":"64","author":"Hansotia","year":"1975","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.tiv.2014.06.008_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03189703","article-title":"Diazepam: kinetic profiles in various brain areas, plasma and erythrocytes after chronic administration in the rat","volume":"10","author":"Hariton","year":"1985","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tiv.2014.06.008_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2014.06.008_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2736(87)90243-4","article-title":"Shape transformation induced by amphiphiles in erythrocytes","volume":"899","author":"Isomaa","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.06.008_b0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1528-1157.2003.09802.x","article-title":"Effects of valproic acid, (carbamazepine), and phenobarbitone on the fatty acid composition of erythrocyte membranes in children","volume":"44","author":"K\u00f6nig","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.tiv.2014.06.008_b0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200709948","article-title":"Lipid bilayer-mediated regulation of ion channel function by amphiphilic drugs","volume":"131","author":"Lundbaek","year":"2008","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tiv.2014.06.008_b0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpc.2009.12.010","article-title":"Effects of the nonsteroidal anti-inflammatory drug naproxen on human erythrocytes and on cell membrane molecular models","volume":"147","author":"Manrique-Moreno","year":"2010","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.tiv.2014.06.008_b0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0704387","article-title":"Commercial taxane formulations induce stomatocytosis and increase blood viscosity","volume":"134","author":"Mark","year":"2001","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/BIR-1978-153-410","article-title":"Rheology of shape-transformed human red cells","volume":"15","author":"Meiselman","year":"1978","journal-title":"Biorheology"},{"key":"10.1016\/j.tiv.2014.06.008_b0120","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1016\/S0021-9258(20)65175-4","article-title":"Lipid translocation across the human erythrocyte membrane","volume":"257","author":"Mohandas","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2014.06.008_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00023210-199708050-00009","article-title":"Citalopram. A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression","volume":"8","author":"Noble","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tiv.2014.06.008_b0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eplepsyres.2006.05.016","article-title":"Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes","volume":"71","author":"Ogawa","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tiv.2014.06.008_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(88)90834-5","article-title":"Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes","volume":"152","author":"Olson","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1993.tb04218.x","article-title":"Changes in red blood cells with valproate therapy","volume":"88","author":"Ozkara","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.tiv.2014.06.008_b0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/abbi.1999.1375","article-title":"Tricyclic antidepressants inhibit the Ca(2+)-dependent ATPase activity from plasma membrane","volume":"370","author":"Plenge-Tellechea","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tiv.2014.06.008_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/0-306-47931-1_3","article-title":"Plasma membrane phospholipid asymmetry","volume":"36","author":"Quinn","year":"2002","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.tiv.2014.06.008_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2362.1993.tb00758.x","article-title":"Binding of cyclosporine by erythrocytes: influence on cell shape and deformability","volume":"23","author":"Reinhart","year":"1993","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.tiv.2014.06.008_b0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/CH-2011-1453","article-title":"Peculiar red cell shapes: fahraeus lecture 2011","volume":"49","author":"Reinhart","year":"2011","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.tiv.2014.06.008_b0165","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.V67.4.1110.1110","article-title":"Red cell rheology in stomatocyte\u2013echinocyte transformation: roles of cell geometry and cell shape","volume":"67","author":"Reinhart","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2014.06.008_b0170","first-page":"33","article-title":"Influence of propofol on erythrocyte morphology, blood viscosity and platelet function","volume":"29","author":"Reinhart","year":"2003","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.tiv.2014.06.008_b0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/cs0790387","article-title":"The effect of amiodarone on the erythrocyte shape and membrane properties","volume":"79","author":"Reinhart","year":"1990","journal-title":"Clin. Sci."},{"key":"10.1016\/j.tiv.2014.06.008_b0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0609.1999.tb01751.x","article-title":"Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood","volume":"62","author":"Reinhart","year":"1999","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.tiv.2014.06.008_b0185","first-page":"227","article-title":"Influence of contrast media (iopromide, ioxaglate, gadolinium-DOTA) on blood viscosity, erythrocyte morphology and platelet function","volume":"32","author":"Reinhart","year":"2005","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.tiv.2014.06.008_b0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-4157(00)00012-5","article-title":"Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects","volume":"1508","author":"Schreier","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2014.06.008_b0195","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood.V79.3.782.782","article-title":"Mechanisms of amphipathic-induced stomatocytosis in human erythrocytes","volume":"79","author":"Schrier","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2014.06.008_b0200","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1073\/pnas.71.11.4457","article-title":"Biological membranes a bilayer couples. A molecular mechanism of drug-erythrocyte interactions","volume":"71","author":"Sheetz","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2014.06.008_b0210","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1515\/znc-1999-3-419","article-title":"The anticancer drug chlorambucil interacts with the human erythrocyte membrane and model phospholipid bilayers","volume":"54","author":"Suwalsky","year":"1999","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.tiv.2014.06.008_b0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/znc-2000-5-624","article-title":"The anticancer drug cisplatin interacts with the human erythrocyte membrane","volume":"55","author":"Suwalsky","year":"2000","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.tiv.2014.06.008_b0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/znc-2004-5-625","article-title":"The antiepileptic drug diphenylhydantoin affects the structure of the human erythrocyte membrane","volume":"59","author":"Suwalsky","year":"2004","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.tiv.2014.06.008_b0225","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.tiv.2006.05.010","article-title":"Effects of the antiepileptic drug carbamazepine on human erythrocytes","volume":"20","author":"Suwalsky","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2014.06.008_b0230","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3177\/jnsv.34.627","article-title":"Alpha-tocopherol and fatty acid levels in red blood cells in patients treated with antiepileptic drugs","volume":"34","author":"Tamai","year":"1988","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.tiv.2014.06.008_b0235","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.2042-7158.1987.tb06982.x","article-title":"Binding of chlorpromazine, phenytoin and aspirin to the erythrocytes and lipoproteins in whole human blood","volume":"39","author":"Tamura","year":"1987","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.tiv.2014.06.008_b0240","first-page":"1","article-title":"Thermodynamic properties of amphiphilic antidepressant drug citalopram HBr","volume":"32","author":"Usman","year":"2010","journal-title":"J. Chem. Soc. Pak."},{"key":"10.1016\/j.tiv.2014.06.008_b0245","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1592\/phco.28.11.1391","article-title":"Therapeutic drug monitoring of phenytoin in critically ill patients","volume":"28","author":"Von Winckelmann","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tiv.2014.06.008_b0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcb.20555","article-title":"Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro","volume":"96","author":"Wong","year":"2005","journal-title":"J. Cell. Biochem."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T19:04:51Z","timestamp":1716923091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0887233314001234"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.06.008","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of injectable neurotropic drugs with the red cell membrane","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}